PET scan and HPV testing during chemoradiation for cervical cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at whether a PET scan (FDG-PET/CT) and blood HPV testing can help track cervical cancer responses during and after standard chemo-radiation. It may help doctors better understand who is responding and who may need different care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your cervical cancer has been confirmed as a specific type: squamous, adenocarcinoma, or adenosquamous.
- Your cancer stage is IB through IVA, and you plan to receive full “radical” radiation plus weekly cisplatin chemotherapy.
- Your cancer has not spread to distant sites (certain small lymph node findings near the radiation area may still be allowed).
- You have not had any previous cancer treatment for this cervical cancer.
- You cannot be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests whether giving additional (adjuvant) chemotherapy after standard chemoradiation can help people whose blood test still shows cancer-related HPV DNA. It may help by lowering the risk of the cervical cancer coming back in people who have a positive blood biomarker after treatment.
This trial uses a combined PET and MRI scan to see if it can better identify the spread of cervical cancer before treatment. It may help guide more personalized care.
This study uses PET-CT scans (a type of imaging that highlights active cancer cells) in people with a specific kind of head and neck cancer. The goal is to see how well the first scan identifies tumors that should be checked again with a second scan, to better guide care with radiotherapy.
This trial is testing whether a newer type of PET/CT scan (F-18 NaF) can better detect blood vessel problems caused by radiation therapy than the standard scan (F-18 FDG) in people with head and neck cancer. If successful, it could lead to better ways to prevent and manage these complications.
This trial uses a special PET scan to look at head and neck cancer cells before treatment. It may help doctors learn more about your cancer and decide if different treatments could work better for you.
This trial tests whether a special PET scan (FMISO PET) can help safely lower the radiation dose for patients with HPV-positive throat cancer. The goal is to reduce side effects while still effectively treating the cancer.
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.